COLUMBIA, Md., Nov. 19 Martek BiosciencesCorporation announced that it intends to release the results of its fourthquarter and fiscal year 2007 on December 12, 2007, at approximately 4:00 p.m.Eastern Time (ET). Following the release, at 4:45 p.m. ET Martek will hold aconference call to discuss the results of its fourth quarter and fiscal year2007 results with investors. The call is expected to be approximately onehour in duration. The conference call will also be available live via theInternet. All interested parties may listen to the call by visiting Martek'sweb site at http://investors.martek.com.
An archived webcast of the conference call will be available on Martek'swebsite for thirty days. In addition, a recorded playback of the call will beavailable for one week and can be accessed by calling 800-633-8284 andentering pass code 21352515.
Martek Biosciences Corporation (Nasdaq: MATK) is a leader in theinnovation and development of DHA omega-3 products that promote health andwellness through every stage of life. The company produces life'sDHA(TM), asustainable and vegetarian source of the omega-3 fatty acid DHA(docosahexaenoic acid), for use in foods, beverages, infant formula, andsupplements. The company also produces life'sARA(TM) (arachidonic acid), anomega-6 fatty acid, from a sustainable, vegetarian source, for use in infantformula. For more information on Martek Biosciences Corporation, visithttp://www.martek.com.Kyle Stults Investor Relations (410) 740-0081 Cassie France-Kelly Public Relations (410) 740-0081
SOURCE Martek Biosciences Corporation